Accessibility Menu
Verastem logo

Verastem

(NASDAQ) VSTM

Current Price$3.80
Market Cap$330.40M
Since IPO (2012)-97%
5 Year-93%
1 Year-39%
1 Month-23%

Verastem Financials at a Glance

Market Cap

$330.40M

Revenue (TTM)

$49.59M

Net Income (TTM)

-$193.96M

EPS (TTM)

-$2.74

P/E Ratio

-1.37

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$3.80

Volume

13,769

Open

$3.75

Previous Close

$3.76

Daily Range

$3.68 - $3.84

52-Week Range

$3.55 - $11.25

Estimated Earnings Date

Aug 6, 2026

VSTM: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Verastem

Industry

Biotechnology

Employees

102

CEO

Dan Paterson

Headquarters

Needham, MA 02494, US

VSTM Financials

Key Financial Metrics (TTM)

Gross Margin

84%

Operating Margin

-3%

Net Income Margin

-4%

Return on Equity

-786%

Return on Capital

-1%

Return on Assets

-85%

Earnings Yield

-72.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$330.40M

Shares Outstanding

87.87M

Volume

13.77K

Avg. Volume

2.32M

Financials (TTM)

Gross Profit

$25.62M

Operating Income

-$170.13M

EBITDA

-$170.13M

Operating Cash Flow

-$137.51M

Capital Expenditure

$0.00

Free Cash Flow

-$137.51M

Cash & ST Invst.

$204.99M

Total Debt

$76.87M

Verastem Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$18.67M

N/A

Gross Profit

$15.62M

N/A

Gross Margin

83.66%

N/A

Market Cap

$330.40M

N/A

Market Cap/Employee

$4.24M

N/A

Employees

78

N/A

Net Income

-$36.59M

+29.8%

EBITDA

-$44.62M

+14.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$181.68M

+54.5%

Total Debt

$85.48M

+11.3%

Accounts Receivable

$10.36M

+5079.0%

Inventory

$2.29M

N/A

Long Term Debt

$79.19M

+7.3%

Short Term Debt

$6.29M

+107.6%

Return on Assets

-85.14%

N/A

Return on Invested Capital

-1.06%

N/A

Free Cash Flow

-$52.12M

-34.8%

Operating Cash Flow

-$52.12M

-34.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RGNXREGENXBIO Inc.
$5.96-2.77%
PRTAProthena Corporation plc
$8.20+3.67%
FDMT4D Molecular Therapeutics, Inc.
$8.54-2.12%
GOSSGossamer Bio, Inc.
$0.17+9.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.47-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.48+0.04%
KEELKeel Infrastructure
$5.39+0.03%
SOFISoFi Technologies
$15.88+0.00%

Questions About VSTM

What is the current price of Verastem?

Verastem is trading at $3.80 per share.

What is the 52-week range for Verastem?

Over the past 52 weeks, Verastem has traded between $3.55 and $11.25.

How much debt does Verastem have?

As of the most recent reporting period, Verastem reported total debt of $85.48M.

How much cash does Verastem have on hand?

Verastem reported $165.55M in cash and cash equivalents in its most recent financial results.

What is Verastem’s dividend yield?

Verastem does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.